
|Videos|May 4, 2016
Neeraj Agarwal from the National Eye Institute: From Benchside to Bedside Research
Author(s)Amy Jacob
Neeraj Agarwal, PhD, FARVO, shared his unique perspective of marrying his prior clinical research to his current institutional landscape at the NIH.
Advertisement
At the 2016 ARVO meeting in Seattle, WA, Neeraj Agarwal, PhD, FARVO, shared his unique perspective of marrying his prior clinical research to his current institutional landscape at the NIH.
He completed extensive research on retinal degeneration and glaucoma, but specifically how the ganglion cells die, and whether neuroprotective research could help save these dying cells, and ultimately save vision.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
4
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
5


























































